Notification of Award Letter 3-10-2023.docx
DOCX document 101 KB Posted
- Attached to
- 75A50322Q00019 SNS Pharmaceutical Buy
- Solicitation number
- 75A50322Q00019
About this file
This award notification letter announces multiple contract awards totaling $29,860,976.46 for the procurement of 26 pharmaceuticals by the Strategic National Stockpile (SNS) to support the mission of the Division of Strategic National Stockpile within the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. Awards were made to six contractors under Solicitation Number 75A50322Q00019 for a one year period of performance from March 1, 2023 through February 29, 2024 to supply various pharmaceutical products. Contractors receiving awards include ASE Direct, Baxter Healthcare, Chartwell RX, Fresenius Kabi, Lovell Government Services, and McKesson Corporation. The letter specifies the products awarded to each contractor along with national drug codes, unit prices and extended total prices. Two products were not awarded due to insufficient funding.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
DEPARTMENT OF HEALTH & HUMAN SERVICES
Administration for Strategic Preparedness and Response Washington, D.C. 20201
ASPR/SNS
2945 Flowers Road Atlanta GA 30341
Date: March 10, 2023
AWARD NOTIFICATION FOR SNS 1 YEAR BULK PHARMA BUY
RFQ 75A50322Q00019
The mission of the Division of Strategic National Stockpile (DSNS), of the United States (U.S.) Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR), is to ensure the availability and rapid deployment of life-saving pharmaceuticals, antidotes, other medical supplies, and equipment necessary to counter the effects of biological, chemical, radiological, natural disasters or other emerging infectious disease agents. When state, local, tribal, and territorial public health and medical systems request federal assistance to support their response efforts, DSNS ensures that the right medicines and supplies get to those who need them most during a public health emergency or pandemic event.
The Strategic National Stockpile (SNS) is a national repository of pharmaceuticals, vaccines, medical supplies, and medical equipment stored in strategic locations around the nation. These assets are designed to supplement state and local public health departments in the event of a large-scale public health emergency that causes local supplies to run out. Pharmaceuticals and Medical Supplies are strategically stored in a network of warehouses across the country for rapid deployment to protect the U.S. population against 21st century health security threats, such as anthrax, botulism, smallpox, plague, tularemia and viral hemorrhagic fevers, as well as emerging infectious diseases, pandemic influenza, natural disasters, and other chemical, biological, radiological, and nuclear incidents.
The goal is to procure 26 Pharmaceuticals for the Strategic National Stockpile.
Period of Performance March 1, 2023- February 29, 2024
Number of Offerors Solicited (UNKNOWN SAM.GOV)
Number of proposals received: 12
AWARD RATIONALE:
As noted in the solicitation in section E. The Government intends to award multiple contracts. The Government may accept any item or group of items of an offer, unless the offeror qualifies the offer by specific limitations. In addition, the Government reserves the right to make an award on any item for a quantity less than the quantity offered at the unit prices offered. These contracts will be awarded to the contractor whose proposal is considered to be the most advantageous to the Government, price and technical factors considered. Technical factors will be more important in the evaluation than price. Lastly, the government reserves the right to reject any proposals that, in its opinion, does not offer fair and reasonable prices.
AWARD DECISION:
Based upon the final evaluation by the Technical Evaluation Panel and the Contracting Officer, it was determined that the following technical proposals were rated technically acceptable and represents low performance risk. In addition, the price proposal is considered best value to the government.
CONTRACTORS:
Contract 75A50323C00007 ASE Direct Inc. (Small Business) 7113 Peach Ct Ste 200 Brentwood, Tennessee 37027-3240
Contract 75A50323C00004 Baxter Healthcare Inc. (Large Business) One Baxter Parkway Deerfield, Illinois 60015
Contract 75A50323C00008 Chartwell RX LLC (Small Business) 77 Brenner Dr Congers, New York 10920-1307
Contract 75A50323C00011 Fresenius Kabi USA, LLC (Large Business) 3 Corporate Dr Lake Zurich, Illinois 60047-8930
Contract 75A50323C00010 (Small Business) Lovell Government Services LLC 223 W Gregory St Pensacola, Florida 32502-4821
Contract 75A50323C00005 (Large Business) McKesson Corporation 6555 State highway 161 Irving, Texas 75039-2402
Contract 75A50323C00006 (Large Business) Pfizer Inc.
235 E 42nd St New York, New York 10017-5703
| Product Proposed |
| Company |
Name
NDC #
Proposed
| UNIT PRICE |
| TOTAL EXTENDED PRICE |
| Albuterol Nebulizer Solution, 0.083% - 2.5mg/3ml vial |
| ASE Direct |
| 00487-9501-25 |
| $ 0.18 |
| $ 441.00 |
| Oxycodone HCL 5mg/Acetaminophen 325mg Tab |
| ASE Direct |
| 71930-0045-52 |
| $ 0.06 |
| $ 138,925.44 |
| Dextrose, 5% and .45% Sodium Chloride for injection, 1000ml solution bag |
| Baxter Inc. |
| 00338-0085-04 |
| $ 1.67 |
| $ 23,730.70 |
| Lactated Ringers Injection, 1000ML (10,000 CS shoud be represented in 140,000 eaches) |
| Baxter Inc. |
| 00338-0117-04 |
| $ 1.72 |
| $ 240,800.00 |
| Levophed (Norepinephrine), 1mg/ml in 4ml amp |
| Baxter Inc. |
| 36000-0162-10 |
| $ 2.40 |
| $ 12,960.00 |
| Sodium Chloride (NaCL) 0.9% for injection, 100ml solution flexi-bag |
| Baxter Inc. |
| 00338-0049-18 |
| $ 1.31 |
| $ 8,640,340.80 |
| Sodium Chloride for inj., 0.9 1000ml flexi-bag (11,071 CS- QTY should be represented in 154,994 eaches) |
| Baxter Inc. |
| 00338-0049-04 |
| $ 1.54 |
| $ 238,690.76 |
| Doxycycline 25mg/5ml oral suspension, powder, 60ml bottle |
| Chartwell |
| 62135-0417-46 |
| $ 13.95 |
| $ 8,600,677.20 |
| Potassium Chloride solution for injection, 2mEq/ml, 20ml vial |
| Fresenius Kabi |
| 63323-965-20 |
| $ 1.20 |
| $ 83,160.00 |
| Rifampin 600mg/vial for injection |
| Fresenius Kabi |
| 63323-351-20 |
| $ 56.87 |
| $ 3,349,643.00 |
| Sterile water for injection, preservative free, 10ml solution vial |
| Fresenius Kabi |
| 63323-185-10 |
| $ 2.64 |
| $ 1,269,312.00 |
| Xylocaine (Lidocaine) HCL MPF 1% without Epinephrine injection, 50ml (10mg/ml) in a 5 ml solution vial |
| Fresenius Kabi |
| 63323-492-57 |
| $ 1.30 |
| $ 36,920.00 |
| Bacitracin zinc, (500u/gm) ointment 30gm tube |
| Lovell |
| 00536-1256-28 |
| $ 1.57 |
| $ 51,885.36 |
| Penicillin G Potassium 20MU |
| McKesson |
| 7086-00127-51 |
| $ 21.95 |
| $ 5,837,370.00 |
| Dopamine HCL solution, for injection, 400mg (40mg/ml) in a 10ml vial- |
| Pfizer |
| 0409-9104-20 |
| $ 2.06 |
| $ 54,899.00 |
| Methylprednisolone sodium succinate for injection,125mg, 2ml powder/diluent 2 chamber vial |
| Pfizer |
| 0009-0047-22 |
| $ 5.99 |
| $ 59,320.80 |
| Voriconazole 200mg 30 Tablet BottleVFEND 200MG FCT 1X30 PBTL US (Alt) |
| Pfizer |
| 0049-3180-30 |
| $ 3.71 |
| $ 621,106.20 |
Multiple Awards Recipients
| ASE Direct |
| Albuterol Nebulizer Solution, 0.083% - 2.5mg/3ml vial |
| 00487-9501-25 |
| $ 441.00 |
| ASE Direct |
| Oxycodone HCL 5mg/Acetaminophen 325mg Tab |
| 71930-0045-52 |
| $ 138,925.44 |
Total
$ 139,366.44
| Baxter Inc. |
| Dextrose, 5% and .45% Sodium Chloride for injection, 1000ml solution bag |
| 00338-0085-04 |
| $ 23,730.70 |
| Baxter Inc. |
| Lactated Ringers Injection, 1000ML |
| 00338-0117-04 |
| $ 240,800.00 |
| Baxter Inc. |
| Levophed (Norepinephrine), 1mg/ml in 4ml amp |
| 36000-0162-10 |
| $ 12,960.00 |
| Baxter Inc. |
| Sodium Chloride (NaCL) 0.9% for injection, 100ml solution flexi-bag |
| 00338-0049-18 |
| $ 8,640,340.80 |
| Baxter Inc. |
| Sodium Chloride for inj., 0.9 1000ml flexi-bag |
| 00338-0049-04 |
| $ 238,690.76 |
Total
$ 9,156,522.26
| Chartwell |
| Doxycycline 25mg/5ml oral suspension, powder, 60ml bottle |
| 62135-0417-46 |
| $ 8,600,677.20 |
Total
$ 8,600,677.20
| Fresenius Kabi |
| Potassium Chloride solution for injection, 2mEq/ml, 20ml vial |
| 63323-965-20 |
| $ 83,160.00 |
| Fresenius Kabi |
| Rifampin 600mg/vial for injection |
| 63323-351-20 |
| $ 3,349,643.00 |
| Fresenius Kabi |
| Sterile water for injection, preservative free, 10ml solution vial |
| 63323-185-10 |
| $ 1,269,312.00 |
| Fresenius Kabi |
| Xylocaine (Lidocaine) HCL MPF 1% without Epinephrine injection, 50ml (10mg/ml) in a 5 ml solution vial |
| 63323-492-57 |
| $ 36,920.00 |
Total
$ 4,739,035.00
| Lovell |
| Bacitracin zinc, (500u/gm) ointment 30gm tube |
| 00536-1256-28 |
| $ 51,885.36 |
Total
$ 51,885.36
| McKesson |
| Penicillin G Potassium 20MU |
| 7086-00127-51 |
| $ 5,837,370.00 |
Total
$ 5,837,370.00
| Pfizer |
| Dopamine HCL solution, for injection, 400mg (40mg/ml) in a 10ml vial- |
| 0409-9104-20 |
| $ 54,899.00 |
| Pfizer |
| Methylprednisolone sodium succinate for injection,125mg, 2ml powder/diluent 2 chamber vials |
| 0009-0047-22 |
| $ 59,320.80 |
| Pfizer |
| Voriconazole 200mg 30 Tablet Bottle VFEND 200MG FCT 1X30 PBTL US (Alt) |
| 0049-3180-30 |
| $ 621,106.20 |
Total
$ 735,326.00
$ 29,860,976.46
| Unawarded Products |
| Product Status |
| NDC's |
| Funded |
| No Award Due To Insufficient Funding |
| Bacitracin, 500u/Polymyxin 10000u, 3.5gm, ophthalmic |
| 24208-0555-55 |
| $ - |
| No Award Due To Insufficient Funding |
| Bactrim sulfamethoxazole, 800mg/trimethoprim 160mg tablets in 100 bottles |
| 65162-0272-50 |
| $ - |
| No Award Due To Insufficient Funding |
| Ciprofloxacin, 250mg/5ml oral suspension, powder, 100ml bottle |
| 62135-0392-42 |
| $ - |
| No Timely BIDS Received |
| Clindamycin phosphate, 150mg/cc in 6cc vial |
| No Award Due To Insufficient Funding |
| Diazepam soln. for inj., 5mg/ml, x 10ml multi-dose vial |
| 0409-1273-32 |
| $ - |
| No Award Due To Insufficient Funding |
| Lidocaine 1% with Epinephrine 30ml vial |
| 63323-487-37 |
| $ - |
| No Award Due To Insufficient Funding |
| Morphine Sulfate, 10mg/ml, 1ml, LL(luer-loc) pre-filled syringe |
| 76045-008-10 |
| $ - |
| No Timely BIDS Received |
| Polymyxin B sulfate/bacitracin zinc double antibiotic ointment, 0.9gm foil packet |
| No Award Due To Insufficient Funding |
| Proparacaine (Hydrochloride Ophthalmic Solution) USP 0.5% 15ML Sterile |
| 24208-0730-06 |
| $ - |
image1.png
File details come from the government source that posted it. Updated .